Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?

Bibliographic Details
Main Author:	Juan Segura-Aguilar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-05-01
Series:	Frontiers in Neuroanatomy
Subjects:	aminochrome dopamine oxidation neurodegeneration astrocytes dopaminergic neurons
Online Access:	http://journal.frontiersin.org/article/10.3389/fnana.2017.00040/full

Similar Items

Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
by: Juan Segura-Aguilar, et al.
Published: (2022-01-01)

Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
by: Juan Segura-Aguilar, et al.
Published: (2018-03-01)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
by: Juan Segura-Aguilar
Published: (2017-01-01)

A Preclinical Model for Parkinson’s Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies
by: Juan Segura-Aguilar, et al.
Published: (2023-03-01)

Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease
by: Yingying Sun, et al.
Published: (2018-11-01)

On the Role of Aminochrome in Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Parkinson's Disease
by: Juan Segura-Aguilar
Published: (2019-03-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Commentary: Evaluation of Models of Parkinson’s Disease
by: Patricia eMuñoz, et al.
Published: (2016-04-01)

A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
by: Giselle Prunell, et al.
Published: (2022-11-01)

Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
by: Alberto Sanchez, et al.
Published: (2021-09-01)

Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
by: Sandro Huenchuguala, et al.
Published: (2024-01-01)

Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase
by: Juan Segura-Aguilar, et al.
Published: (2022-01-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model
by: Atsushi Fujita, et al.
Published: (2018-08-01)

Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy
by: Khalid M. Alharthy, et al.
Published: (2024-02-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson’s disease
by: Chun Yang, et al.
Published: (2020-06-01)

Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease
by: Eric Wildon Kostuk, et al.
Published: (2018-05-01)

Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron–glia crosstalk
by: Ana Saavedra, et al.
Published: (2006-09-01)

Dietary plant lectins appear to be transported from the gut to gain access to and alter dopaminergic neurons of Caenorhabditis elegans, a potential etiology of Parkinson’s disease
by: Jolene eZheng, et al.
Published: (2016-03-01)

Morphological Heterogeneity of the Endoplasmic Reticulum within Neurons and Its Implications in Neurodegeneration
by: Sreesha Sree, et al.
Published: (2021-04-01)

On the Role of Iron in Idiopathic Parkinson’s Disease
by: Sandro Huenchuguala, et al.
Published: (2023-11-01)

Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats
by: Lujain Bader Eddin, et al.
Published: (2023-03-01)

Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease
by: Melanie Bousquet, et al.
Published: (2011-02-01)

Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
by: Anna Kolacheva, et al.
Published: (2024-01-01)

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
by: Katrin Simmnacher, et al.
Published: (2020-01-01)

Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model
by: Noor Azzizah Omar, et al.
Published: (2023-11-01)

Parkinson’s Disease: Exploring Different Animal Model Systems
by: Engila Khan, et al.
Published: (2023-05-01)

Characteristic response of striatal astrocytes to dopamine depletion
by: Yao-Feng Zhu, et al.
Published: (2020-01-01)

Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
by: Julieta Mendes-Oliveira, et al.
Published: (2023-12-01)

The Gene Expression of Proteins Involved in Intercellular Signaling and Neurodegeneration in the Substantia Nigra in a Mouse Subchronic Model of Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2023-02-01)

Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
by: Anja Pišlar, et al.
Published: (2018-11-01)

Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis
by: Maria Francesca Serapide, et al.
Published: (2020-03-01)

Vulnerable Parkin Loss-of-Function Drosophila Dopaminergic Neurons Have Advanced Mitochondrial Aging, Mitochondrial Network Loss and Transiently Reduced Autophagosome Recruitment
by: Juliana Cackovic, et al.
Published: (2018-02-01)

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease
by: Ramesh Pariyar, et al.
Published: (2022-02-01)

Dopamine dysregulation syndrome in Parkinson’s disease
by: A V Nikitina, et al.
Published: (2013-03-01)

Nuevos modelos transgénicos para el estudio de la enfermedad de Parkinson basados en sistemas de edición con nucleasas
by: J.A. Cota-Coronado, et al.
Published: (2020-09-01)

Targeting microglial NLRP3 in the SNc region as a promising disease‐modifying therapy for Parkinson's disease
by: Chen Qiao, et al.
Published: (2022-11-01)

Interleukin-1β mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures
by: Ana Saavedra, et al.
Published: (2007-01-01)

Understanding miRNA Based Gene Regulation in Parkinson’s Disease: An in silico Approach
by: Surya Narayan Rath, et al.
Published: (2020-03-01)